Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany635-93-8 5-Chlorosalicylaldehyde 98%
5-Chlorosalicylaldehyde
5-Chlorosalicylaldehyde
5-Chlorosalicylaldehyde

635-93-8 5-Chlorosalicylaldehyde 98%

Price Get Latest Price
Packge 1MT1kg5kg10kg25kg
  • Min. Order:1MT
  • Time:2023-04-29

Product Details

  • Product Name5-Chlorosalicylaldehyde
  • CAS No.635-93-8
  • EINECS No.211-244-4
  • MFC7H5ClO2
  • MW156.57
  • AppearanceCrystalline PowderWhite to very slightly yellow
  • Melting point 100-102 °C(lit.)
  • Boiling point 217.69°C (rough estimate)
  • density 1.2683 (rough estimate)
  • storage temp. Keep in dark place,Sealed in dry,Room Temperature

Company Profile Introduction

Neochemsys Laboratories Private Limited offers a wide range of chemical synthesis services tailor-made to your requirements! Whether you are a niche biotech firm or global pharma company, we cover the entire molecular life cycle and are experienced in collaborating with a diverse range of clients. We have consistently delivered diverse set of NCE development programs for our customers with a track record of bringing value based on quality, pricing and responsiveness. With a strong team of scientists and process engineers, we are up to any challenge involving complex chemical synthesis from route scouting, process development, scale-up to commercial scale. As a leading small molecule contract manufacturing organization (CMO), our world-class manufacturing facilities are equipped with flexible and versatile infrastructure, tailored to fit the smaller volume but more complex chemistry coming out of the development pipelines today. And we are continuously investing in making it better!

Neochemsys Laboratories Pvt Ltd

2Y Telangana India
  • Since:2023-10-23
  • Address: FLAT No - 102, PLOT No 1066-69, SRIKALARESIDENCY, PRAGATHI NAGAR, PRAGATHI NAGAR, KUAKATPALLY, HYDER
INQUIRY